Publications en collaboration avec des chercheurs de Heidelberg University (11)

2023

  1. Haploidentical Versus Matched Unrelated Donor Transplants Using Post-Transplantation Cyclophosphamide for Lymphomas

    Transplantation and Cellular Therapy, Vol. 29, Núm. 3, pp. 184.e1-184.e9

2022

  1. Allogeneic hematopoietic stem cell transplantation for adult HLH: a retrospective study by the chronic malignancies and inborn errors working parties of EBMT

    Bone Marrow Transplantation, Vol. 57, Núm. 5, pp. 817-823

2020

  1. Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma – a LWP-EBMT study

    British Journal of Haematology, Vol. 188, Núm. 5, pp. 745-756

2019

  1. Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party

    Cancer, Vol. 125, Núm. 1, pp. 90-98

  2. Outcomes of Haploidentical Transplantation in Patients with Relapsed Multiple Myeloma: An EBMT/CIBMTR Report

    Biology of Blood and Marrow Transplantation, Vol. 25, Núm. 2, pp. 335-342

  3. PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBCL

    Blood Advances, Vol. 3, Núm. 3, pp. 360-369

2018

  1. Brentuximab vedotin prior to allogeneic stem cell transplantation in Hodgkin lymphoma: a report from the EBMT Lymphoma Working Party

    British Journal of Haematology, Vol. 181, Núm. 1, pp. 86-96

2017

  1. Haploidentical transplant in patients with myelodysplastic syndrome

    Blood Advances, Vol. 1, Núm. 22, pp. 1876-1883

  2. Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation

    Bone Marrow Transplantation, Vol. 52, Núm. 3, pp. 372-380

2015

  1. Second allo-SCT in patients with lymphoma relapse after a first allogeneic transplantation. A retrospective study of the EBMT Lymphoma Working Party

    Bone Marrow Transplantation, Vol. 50, Núm. 6, pp. 790-794

2003

  1. Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: Influence of dose and stem cell source shows better outcome with rich marrow

    Blood, Vol. 102, Núm. 8, pp. 3043-3051